Wednesday
July 20, 2016
10: 00 am ET
7: 00 am PT
4: 00 pm CEST
DURATION
60 minutes
COST
Complimentary
Speakers
Continuous BioProcessing:
Not a Revolution but
an Evolution
The next evolutionary frontier for the biopharmaceutical
industry is the widespread adoption of integrated continuous
bioprocessing for biologics manufacturing. The key to its
success, however, is the availability of novel upstream and
downstream technologies that will not only reduce facility
footprint, capital expenses, and product cost of goods, but
will also increase process productivity, fexibility, and further
facilitate the utilization of single-use and/or disposable
technologies. This presentation will provide a risk-based
and data-driven overview of an integrated bioprocessing
platform, highlighting challenges and opportunities for
product development.
A live Q&A; session will follow the presentations, ofering
you a chance to pose questions to our expert panelists.
Who Should Attend
• Process development scientists
• Biomanufacturing and scale-up technologists
• Chief scientifc ofcers and chief technical ofcers
•
Tech transfer specialists and pilot-scale scientists
•
CMO scientists
Free Registration!
www.GENengnews.com/continuous
Webinars
You Will Learn
• The evolving nature of continuous
bioprocessing technologies
.
• Scalability solutions.
• Practical applications and methodologies
of continuous bioprocessing systems.
• That decreased costs, smaller operational
footprint, and improved asset utilization
are invaluable benefts.
Produced with support from
Engin
Ayturk, Ph.D.
Senior R&D; Manager
BioPharm Applications
R&D;, Integrated
Continuous BioProcessing
Pall Life Sciences
Peter Levison
Senior Marketing Director
Downstream Processing
Pall Life Sciences